Recombinant Mouse Tumor necrosis factor receptor superfamily member 26 protein (Fc Chimera)
Be the first to review this product! 리뷰 제출
|
(0 출판물)
Recombinant Mouse Tumor necrosis factor receptor superfamily member 26 protein (Fc Chimera) is a Mouse Fragment protein, in the 1 to 162 aa range, expressed in HEK 293 cells, with >95%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE.
대체 명칭 보기
Tnfrh3, Tnfrsf26, Tumor necrosis factor receptor superfamily member 26, TNF receptor homolog 3
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Mouse Tumor necrosis factor receptor superfamily member 26 protein (Fc Chimera) (AB276999)
SDS-PAGE analysis of ab276999
Reactivity 정보
서열 정보
특성 및 보관 정보
제형
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TNFRSF26 contributes to immune system regulation and cellular apoptosis. It plays a role in complex assemblies that mediate interactions between different signaling molecules further influencing cell death and survival. Through its ligand-binding activities TNFRSF26 can activate specific signaling cascades that modulate inflammation and immune cell activation. This protein's function is critical in maintaining immune homeostasis and shaping the body’s response to various signals.
Pathways
TNFRSF26 plays a significant role in the TNF signaling pathway which controls diverse cellular responses including inflammation apoptosis and cell proliferation. The pathway involves several key proteins including TNF and TRAF (TNF receptor-associated factor) proteins which help transmit signals initiated by receptor-ligand binding. Another important pathway related to TNFRSF26 is the NF-kB pathway known for regulating immune response. This pathway supports adaptive and innate immune responses by mediating gene expression necessary for responding to external stressors effectively.
일반 정보
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com